ATE554773T1 - Synergistische kombination von pinaverium bromid und dimethicon oder simethicon - Google Patents

Synergistische kombination von pinaverium bromid und dimethicon oder simethicon

Info

Publication number
ATE554773T1
ATE554773T1 AT06783810T AT06783810T ATE554773T1 AT E554773 T1 ATE554773 T1 AT E554773T1 AT 06783810 T AT06783810 T AT 06783810T AT 06783810 T AT06783810 T AT 06783810T AT E554773 T1 ATE554773 T1 AT E554773T1
Authority
AT
Austria
Prior art keywords
present
pharmaceutical industry
simethicon
dimethicon
action
Prior art date
Application number
AT06783810T
Other languages
English (en)
Inventor
Armenta Maria Elena Garcoea
Ochoa Victor Guillermo Alvarez
Murillo Josefina Santos
Armenta Patricia Garcoea
Abdala Leopoldo De Jesus Espinosa
Original Assignee
World Trade Imp Export Wtie A G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Trade Imp Export Wtie A G filed Critical World Trade Imp Export Wtie A G
Application granted granted Critical
Publication of ATE554773T1 publication Critical patent/ATE554773T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
AT06783810T 2006-03-09 2006-07-27 Synergistische kombination von pinaverium bromid und dimethicon oder simethicon ATE554773T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXPA2006002746 2006-03-09
PCT/MX2006/000081 WO2007102725A1 (es) 2006-03-09 2006-07-27 Combinación sinérgica de bloqueadores de los canales de calcio tipo-l selectivos para tracto gastrointestinal y un silicon inerte

Publications (1)

Publication Number Publication Date
ATE554773T1 true ATE554773T1 (de) 2012-05-15

Family

ID=40149861

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06783810T ATE554773T1 (de) 2006-03-09 2006-07-27 Synergistische kombination von pinaverium bromid und dimethicon oder simethicon

Country Status (10)

Country Link
EP (1) EP2020234B1 (de)
AT (1) ATE554773T1 (de)
BR (1) BRPI0621449B8 (de)
CR (1) CR10278A (de)
CY (1) CY1113588T1 (de)
EC (1) ECSP088725A (de)
ES (1) ES2387620T3 (de)
HN (1) HN2008001399A (de)
PL (1) PL2020234T3 (de)
WO (1) WO2007102725A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009028451A1 (de) 2009-08-11 2011-02-17 Robert Bosch Gmbh Kollisionsüberwachung für ein Kraftfahrzeug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2748206B1 (fr) * 1996-05-06 1998-07-31 Solvay Pharma Utilisation de bromure de pinaverium dans la prevention des phenomenes proliferatifs des cellules du tractus hepatodigestif et des maladies qui en resultent

Also Published As

Publication number Publication date
ECSP088725A (es) 2008-10-31
ES2387620T3 (es) 2012-09-27
EP2020234A1 (de) 2009-02-04
WO2007102725A1 (es) 2007-09-13
BRPI0621449B8 (pt) 2021-07-20
EP2020234A4 (de) 2010-07-21
HN2008001399A (es) 2010-10-01
BRPI0621449A2 (pt) 2011-12-13
EP2020234B1 (de) 2012-04-25
CY1113588T1 (el) 2016-06-22
CR10278A (es) 2008-11-26
PL2020234T3 (pl) 2012-10-31
BRPI0621449B1 (pt) 2020-11-17

Similar Documents

Publication Publication Date Title
CY1121853T1 (el) Συνδυαστικη θεραπεια για την αγωγη του διαβητη
BRPI0708640A8 (pt) composição farmacêutica, e, métodos para tratar um paciente com dor de cabeça de enxaqueca, para tratar um paciente com dor e para tratar um paciente com enxaqueca
NZ623495A (en) Oral formulations of cytidine analogs and methods of use thereof
DE602005023203D1 (de) Zur verhinderung von missbrauch entworfene, feste arzneimittelform zur oralen verabreichung
BRPI0518255A2 (pt) mÉtodos de tratamento ou prevenÇço de uma lesço do sistema nervoso central, para reduzir ou evitar um efeito adverso, e composiÇço farmacÊutica
NO20090887L (no) Fremgangsmate for behandling og forebygging av mukositt
MX2021000376A (es) Composiciones tópicas para el alivio del dolor.
DE602006017728D1 (de) Krebsbehandlung mittels fts und 2-deoxyglucose
TW200734334A (en) Treatment of substance abuse
WO2005074536A3 (en) Compositions and methods using proton pump inhibitors
NO20064287L (no) Dalbavancin-materialer for behandling av bakterielle infeksjoner
MX2019001850A (es) Formulaciones para administracion oral de principios activos.
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
MX2007010886A (es) Metodos y formulaciones de acarbosa para tratar constipacion cronica.
NO20091644L (no) Hurtig desintegrerende, lyofiliserte orale formuleringer av en trombinreseptorantagonist
CO6220945A2 (es) Uso de una composicion que comprende formoterol y dipropianato de beclometasona para la prevencion y/o tratamiento de una exacerbacion de asma
EA201170405A1 (ru) Монотерпены для лечения заболеваний дыхательных путей, в частности, бронхолегочных заболеваний
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
JP2011500589A5 (de)
MX2008011454A (es) Uso novedoso de agentes antihistaminicos para el tratamiento preventivo o temprano de sindromes inflamatorios, en particular los que son accionados por togavirus.
EA201001100A1 (ru) Фармацевтическая композиция на основе гепатопротектора и пребиотика, получение и применение
RU2011148355A (ru) Применение аллопуринола для ладонно-родошвенного синдрома
ATE554773T1 (de) Synergistische kombination von pinaverium bromid und dimethicon oder simethicon
AR075866A1 (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica.
BRPI0918593A2 (pt) composição farmacêutica para uso no tratamento de infecções transmitidas sexualmente